Resource use and costs: average annual amounts of healthcare resource use and costs per patient in CD versus non-CD cohorts (for a maximum of 10 years before and after diagnosis).

1<p>Standard error in parentheses.</p>2<p>Confidence interval in parentheses.</p

Average annual cost for prescriptions per patient by British National Formulary (BNF) category in CD versus non-CD cohorts (for a maximum of 10 years before and after diagnosis).

1<p>Standard error in parentheses.</p>2<p>confidence interval in parentheses.</p>3<p>Gluten-free and special diet products.</p

Average annual costs per patient in CD versus non-CD cohorts stratified by date of diagnosis/pseudo-diagnosis date (1987–1999; 2000–2005).

1<p>Standard error in parentheses.</p>2<p>Confidence interval in parentheses.</p

Cases selection profile.

<p>Cases selection profile.</p

Details on observation time and personal characteristics of coeliac disease cohort and control cohort¹.

1<p>Values are numbers and percentages are presented in parentheses.</p>2<p>Matching was performed between cases and controls not on individual years.</p>3<p>most recent.</p

Total costs before and after diagnosis (or pseudo-diagnosis) of coeliac disease.

<p>Total costs before and after diagnosis (or pseudo-diagnosis) of coeliac disease.</p

Total costs before and after diagnosis (or pseudo-diagnosis) of coeliac disease.

<p>Comparison between PRE-2000 and POST-1999 DIAGNOSIS.</p